Oxamniquine
In the US, Oxamniquine (oxamniquine systemic) is a member of the drug class anthelmintics and is used to treat Schistosoma mansoni.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
P02BA02
CAS registry number (Chemical Abstracts Service)
0021738-42-1
Chemical Formula
C14-H21-N3-O3
Molecular Weight
279
Therapeutic Category
Anthelmintic agent
Chemical Name
6-Quinolinemethanol, 1,2,3,4-tetrahydro-2-[[(1-methylethyl)amino]methyl]-7-nitro-
Foreign Names
- Oxamniquinum (Latin)
- Oxamniquin (German)
- Oxamniquine (French)
- Oxamniquina (Spanish)
Generic Names
- Oxamniquine (OS: DCF, USAN, BAN)
- UK 4271 (IS: Pfizer)
- Oxamniquine (PH: Ph. Franç. X, Ph. Int. 4, USP 23)
- Oxamniquinum (PH: Ph. Int. 4)
Brand Names
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
